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Abstract
CD4+ T-cell loss is the hallmark of HIV-1 infection. CD4 counts fall more rapidly in advanced disease when CCR5-tropic viral
strains tend to be replaced by X4-tropic viruses. We hypothesized: (i) that the early dominance of CCR5-tropic viruses results
from faster turnover rates of CCR5+ cells, and (ii) that X4-tropic strains exert greater pathogenicity by preferentially
increasing turnover rates within the CXCR4+ compartment. To test these hypotheses we measured in vivo turnover rates of
CD4+ T-cell subpopulations sorted by chemokine receptor expression, using in vivo deuterium-glucose labeling. Deuterium
enrichment was modeled to derive in vivo proliferation (p) and disappearance (d*) rates which were related to viral tropism
data. 13 healthy controls and 13 treatment-naive HIV-1-infected subjects (CD4 143–569 cells/ul) participated. CCR5-
expression defined a CD4+ subpopulation of predominantly CD45R0+ memory cells with accelerated in vivo proliferation
(p = 2.50 vs 1.60%/d, CCR5+ vs CCR52; healthy controls; P,0.01). Conversely, CXCR4 expression defined CD4+ T-cells
(predominantly CD45RA+ naive cells) with low turnover rates. The dominant effect of HIV infection was accelerated turnover
of CCR5+CD45R0+CD4+ memory T-cells (p= 5.16 vs 2.50%/d, HIV vs controls; P,0.05), naı¨ve cells being relatively unaffected.
Similar patterns were observed whether the dominant circulating HIV-1 strain was R5-tropic (n = 9) or X4-tropic (n = 4).
Although numbers were small, X4-tropic viruses did not appear to specifically drive turnover of CXCR4-expressing cells
(p = 0.54 vs 0.72 vs 0.44%/d in control, R5-tropic, and X4-tropic groups respectively). Our data are most consistent with
models in which CD4+ T-cell loss is primarily driven by non-specific immune activation.
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Introduction
The cardinal pathological feature of the acquired immunode-
ficiency syndrome (AIDS) is progressive CD4+ T cell depletion,
but the immuno-pathological mechanisms linking chronic HIV
infection with slow but progressive loss of CD4 cells, over periods
measured in years, remain incompletely explained.[1] HIV
preferentially infects CD4+ T cells, resulting in death of the host
cell, but direct viral cytopathicity fails to adequately explain the
kinetics and extent of CD4 loss.[2,3] Other factors must be
important and we now recognize altered immune homeostasis,
immune activation and infection of gut lymphoid tissue as critical
factors.
Any change in lymphocyte numbers must be considered in the
context of immune homeostasis, the self-regenerative capacity of
lymphoid populations. Homeostasis can be defined and measured
in terms of three fluxes for each lymphocyte subset: proliferation,
death and phenotype transformation. In uninfected individuals,
these fluxes are balanced, maintaining roughly constant T-cell
numbers for decades, and together these fluxes can be expressed as
a ‘‘turnover’’ rate. Even in chronic-phase HIV-infected individ-
uals, T-cell populations remain roughly stable on a day-to-day
basis. Although CD4 cells are lost, loss rates are orders of
magnitude less than everyday turnover, such that typical depletion
rates represent a mismatch between proliferation and death of
only ,1%; hence even in progressive HIV-1 infection, at least
99% of dying lymphocytes are replaced on a daily basis.
Proliferation may be either homeostatic or activation-induced;
the latter tends to occur in bursts and, for naı¨ve cells, is usually
associated with phenotype change to ‘‘memory’’ phenotype. Such
cells would thus be lost from the naı¨ve compartment. However, in
a homeostatic system, their loss will be matched by production of
new naı¨ve cells, predominantly in adult humans by proliferation
within the peripheral compartment, as T-cell homeostasis
continues unimpeded long after thymic involution.[4,5]
Accelerated T-cell turnover [6–8] appears pivotal in causing
retroviral-induced failure of T-cell homeostasis; thus the absence
of a proliferative response in sooty mangabey SIV infection is
associated with non-pathogenicity.[9] But what drives such
turnover? Early paradigms invoked a homeostatic response to
direct virus-mediated cell death.[10] However, this model alone
cannot explain the loss of virtually the entire CD4+ compartment
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in advanced disease, not least because typically only about 1 in
1,000 CD4 cells are infected in untreated patients.[11,12] Nor
does it explain the correlation of CD8 and CD4 T-cell
proliferation seen, for example, in bromodeoxyuridine (BrdU)-
labeling studies.[13] Immune activation, by contrast, could affect
the whole pool, and indeed correlates with disease progres-
sion,[14] Although HIV-specific cells are preferentially infected by
HIV,[15] CD4+ activation is not confined to HIV-specific cells.
Activation of a broad repertoire of cells may result from
gastrointestinal microbial translocation [1] and/or expansion of
the gastrointestinal virome [16] as a consequence of depletion of
gastrointestinal lymphoid tissue, an early target of HIV infection,
However, immune activation per se, does not inevitably lead to
CD4 depletion, as illustrated by other chronic inflammatory states.
Failure of homeostatic replacement must also occur and may be
related to cell-specific targeting by HIV infection. Viral entry into
CD4+ T-cells requires specific binding to chemokine receptors
alongside CD4, either CCR5 or CXCR4 for HIV-1. R5-tropic
strains of virus predominate in early infection. It has been
suggested that this relates to the abundance of CCR5-expressing
macrophages at sites of primary infection, but an alternative
explanation suggests that host cell division rates may determine the
dominant viral type.[17,18] According to this model, CCR5-
expressing cells, predominantly memory/activated T-cells have
higher rates of turnover,[19,20] and thus produce more of the
virus which preferentially infects them, in this case R5-tropic virus.
Conversely, CXCR4-expressing cells are mostly naive cells, which
are slowly-dividing,[19,21] and so produce less (X4-tropic) virus.
Why then is the emergence of X4-tropic strains associated with
accelerated disease progression and more dramatic loss of CD4
cells?[22,23] We hypothesized that X4-tropic viruses may
preferentially induce more immune activation and higher turnover
in the (CXCR4+) cell populations they infect. Since these include
predominantly naive cells, which are usually only replaced very
slowly,[19,21] the switch to X4-tropism may exceed compensatory
immune homeostasis. If this is the case, in vivo CD4 kinetics will
vary according to viral tropism: CCR5+ cells will be more affected
by R5-tropic viruses whilst CXCR4+ cells will be more affected by
X4-tropic viruses. The converse hypothesis, that non-specific
effects, such as immune activation, which drive CD4 cell depletion
are more marked with X4-tropic viruses,[24] would predict CD4
kinetics independent of viral tropism. We tested these hypotheses
by measuring in vivo cell proliferation and disappearance rates
using deuterated glucose incorporation.[19,25] First, we investi-
gated the relationship between chemokine receptor expression and
turnover in defined CD4 memory and naı¨ve cell populations in
both healthy and HIV-infected subjects. Secondly, we investigated
the effect of HIV infection on turnover rates of these chemokine
receptor expression-defined populations of CD4+ T-cells. Thirdly
we investigated whether the cell subtype specific effects of HIV
infection were dependent upon the chemokine receptor tropism of
the dominant circulating virus.
Results
Subject characteristics
In vivo CD4+ T-cell turnover measurements were made using
deuterium glucose labeling in 13 healthy controls and 13 HIV-
positive subjects (Table 1). Nine of the HIV-positive subjects had
predominantly R5-tropic and four X-4 tropic virus. Groups were
balanced for gender. HIV-positive subjects tended to be older than
control subjects (mean 38 vs 25 years) and, as expected, had lower
mean CD4 counts than control subjects (mean [range]: 435 [143–
569] versus 779 [503–1182] cells/ul; P,0.001), but higher CD8
counts (1041 [340–2304] versus 441 [255–733] cells/ul; P,0.001;
Table 1). One subject (RH07), who was initially assessed during a
phase of rapid CD4 decline, was reevaluated 15 months after
starting antiretroviral therapy when viral load was undetectable
and CD4 count rising.
Cell turnover and HIV infection
When we investigated in vivo cell turnover in specific CD4+
memory and naı¨ve T-cell subpopulations we made five key
observations:
1. CCR5+ expression defines a fast turnover sub-
population of CD4+ CD45R0+ memory cells. Firstly, there
was a clear relationship between memory cell turnover and CCR5
expression. In healthy subjects, CCR5 positive CD4+CD45R0+ T-
cells had higher in vivo proliferation rates than CCR5-negative
CD4+CD45R0+ cells (Figure 1A), when expressed either as peak
enrichment values, which give a minimum estimate for turnover
rate (Table S1, CCR5+, 2.0260.67 vs CCR52 1.1160.40%;
P,0.001; mean6 1SD and hereafter), or as modeled proliferation
rates (p, Table 2 and Figure 1C, CCR5+, 2.5061.26 vs CCR52
1.6060.75%/d; P = 0.003). The same observation was made in
HIV+ subjects; CCR5+ memory cells proliferated about twice as
fast as CCR52 memory cells (peak enrichment: Figure 1B, Table
S1, CCR5+, 3.4461.89 vs CCR52 1.8760.78%, P = 0.016;
proliferation rates: Table 2, Figure 1D, CCR5+, 5.1664.51 vs
CCR52 2.3561.05%/d, P = 0.046). Disappearance rates (d*,
Table S2, Figure 1E) consistently exceeded proliferation rates; this
is expected in short-term labeling studies where disappearance
rates only reflect the rate of loss of the small sub-fraction of
recently-divided cells which inherently have high early post-
labeling death-rates, whatever their phenotype or origin [19].
Despite this constraint and large inter-individual variation, we did
observe an effect of CCR5-expression on the disappearance rates
of labeled cells in HIV+ (but not control) subjects, CCR5+ cells
Author Summary
Loss of CD4+ T-cells is the cardinal feature of HIV/AIDS,
resulting in pathological susceptibility to opportunistic
infections. Mechanisms underlying CD4-depletion remain
unclear, although the role of chronic immune activation is
now well-recognized. Selectivity of the virus for its co-
receptor target (either chemokine-receptor CCR5 or
CXCR4) is also pivotal. We explored the relationship
between these two factors by directly measuring in vivo
proliferation rates of CD4+ T-cell subpopulations according
to their expression of chemokine-receptors and the
tropism of circulating virus in clinically-well people with
HIV infection, and healthy human controls. We used stable
isotope labeling with deuterium-labeled glucose to quan-
tify proliferation and disappearance rate constants of CD4+
T-cells sorted by CCR5, CXCR4 and CD45R0/RA expression.
We found that CCR5-expression defines a high turnover
subpopulation which is therefore likely to be preferentially
infected and produce more (CCR5-tropic) virus. CXCR4-
tropic viruses induced a similar pattern of proliferation as
R5-tropic strains, with no apparent selectivity for viral
strains to induce proliferation in their targeted subpopu-
lations. This study is significant in providing directly-
measured in vivo human data supporting postulates
generated in ex vivo human studies and SIV models
suggesting that non-specific factors, such as immune
activation, rather than cell-specific cytotoxicity, are dom-
inant drivers for HIV pathogenesis.
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disappearing from the circulation more rapidly than CCR52 cells
(Table S2; Figure 1F; P = 0.003).
Since CCR5 expression appeared to define a memory T-cell
subset with accelerated turnover in all subjects, we sought to
further characterize such cells phenotypically. We found that
CCR5-expression was associated with a more activated and
differentiated phenotype, compared to CCR5-negative memory
cells. Similar observations have been made in SIV-infected
macaques.[26] When compared to CCR52 cells, CCR5+ memory
cells also had lower levels of CCR7, CD27 (in both control and
HIV+ subjects), and CXCR4-expression, although in two HIV-
infected subjects CXCR4 levels were increased (Figure S1).
CCR5+ and CCR52 cells exhibited similar levels of expression
of CD25, CD28, and CD95. Most CCR5+ cells thus appear to
have an effector-memory phenotype. Interestingly, in HIV
subjects CD45R0+CXCR42 cells had a significantly more
differentiated phenotype, having lost more CD27 and CCR7
(Figure S1).
2. HIV infection dramatically accelerates the turnover of
CCR5+ memory (CD4+CD45R0+) CD4+ T cells. The most
marked effect of HIV on the kinetics of CD4+ T-cells was found in
the CCR5+ subset where HIV infection more than doubled
modeled proliferation rates (5.1664.51 versus 2.5061.26%/d,
HIV+ vs controls, P = 0.046, ratio (HIV dynamic factor)
Table 1. Subject characteristics.
Identifier Age Gender Viral Load Log VL CD4 CD4 slope
1 CD8 Viral Tropism
(years) copies/ml 6106 cells/L 6106 cells/month 6106 cells/L
Controls
C27RR 30 M N/A N/A 870 0 430 N/A
RC01 23 F N/A N/A 701 0 611
RC02 23 M N/A N/A 698 0 478 N/A
RC03 35 F N/A N/A 680 0 392 N/A
RC04 20 F N/A N/A 1182 0 491 N/A
RC05 20 F N/A N/A 1159 0 733 N/A
RC06 31 M N/A N/A 643 0 373 N/A
RC07 22 M N/A N/A 993 0 449 N/A
RC08 24 M N/A N/A 831 0 280 N/A
RC09 26 M N/A N/A 560 0 557 N/A
RC10 25 F N/A N/A 574 0 416 N/A
RC11 22 M N/A N/A 503 0 255 N/A
RC12 26 M N/A N/A 731 0 266 N/A
Mean 25.2 779 441
SD 4.5 219 139
HIV-positive
R5-tropic
RH02 33 M 14,300 4.16 525 27.8 1,817 R5
RH04 33 M 105,000 5.02 427 212.9 851 R5
RH05 42 M 1,640 3.21 569 21.4 858 R5
RH06 31 M 39,100 4.59 533 +1.4 1,179 R5
RH07 55 F 586,000 5.77 143 216.1 340 R5
RH08 49 M 3,920 3.59 522 +0.4 599 R5
RH10 38 F 197 2.29 528 22.0 592 R5
RH12 37 M 46,700 4.67 352 24.1 1,155 R5
RH13 41 F 62,000 4.79 282 25.6 727 R5
X4-tropic
RH01 31 M 67,291 4.83 474 +1.9 2,304 X4
RH09 21 F 23,200 4.37 310 25.9 1,046 X4
RH11 37 M 22,800 4.36 523 +3.3 1,189 X4
RH14 49 F 11,800 4.07 472 24.2 877 X4
All HIV-positive
Mean 38.2 75,688 4.29 435 24.1 1,041
SD 9.1 156,378 0.88 127 5.7 527
N/A – not applicable;
1assumed to be zero for controls.
doi:10.1371/journal.ppat.1003310.t001
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2.07,Table 2). This was also apparent as an increase in mean peak
enrichment (Table S1; P,0.05). Although numbers of subjects
with X4-tropic virus were small, the effect appeared similar for
both viral tropism cohorts (Figure 2A). There was a trend towards
higher CCR5+ memory cell (CD4+CD45R0+) turnover in subjects
with higher viral loads (Figure 2B, P = 0.023).
Since the kinetics of CCR5+ cells differed between HIV+ and
control subjects, we investigated whether this might be associated
with a difference in the phenotype of such cells. This did not
appear to be the case for several key phenotypic markers
(Figure 2C). CD45R0+CCR5+ cells in HIV-infected subjects
tended to be CD28+ (86%), CD27+ (59%), and CD95+ (60%),
whilst exhibiting intermediate staining for CCR7 (39%), CD25
(29%), and CD62L (49%), and low levels of staining for CD45RA
(5%) and CXCR4, except in two subjects (mean 31%). Similar
patterns of co-staining for these markers, albeit with less
variability, was observed on CCR5+ cells in control subjects
(except CD62L and CD95 which were not analyzed in control
subjects).
3. HIV infection accelerates turnover of CCR5-negative
CD4+CD45R0+ memory cells, predominantly in the CXCR4-
negative subpopulation. When we investigated CCR52
memory cells, we found that HIV also accelerated the turnover
of such cells by a factor of 1.47 overall (Table 2), although, in
absolute terms, they still proliferated less quickly than correspond-
ing CCR5+ cells. Mean peak enrichment was increased by about
70% (1.87 vs 1.11%; P = 0.004; Figure 3A) and modeled
proliferation rate by ,50% (Figure 3B; P = 0.047). Disappearance
rates were similar for both control and HIV-positive populations
(Table S2).
We next tested whether the effect of HIV infection on CCR52
cells was related to the interaction between CXCR4-receptor
expression and viral tropism by sorting cells for CXCR4-receptor
co-expression prior to deuterium analysis. We found high rates of
proliferation in CXCR4-negative CCR52 cells (Figure 3C,
P = 0.018), whilst cells expressing CXCR4 had low rates of
proliferation, similar to those in control CCR52 cells (Figure 3C).
Although this subgroup analysis was only performed in three
subjects with an X4-tropic virus analyzed, there did not appear to
be any preferential stimulation of proliferation in CXCR4+
memory cells in those with X4-tropic virus; conversely, prolifer-
ation appeared to be accelerated in CXCR42 cells just as much in
subjects with X4-tropic virus as in those with R5-tropic strains
(Figure 3D), suggesting that there is no selective effect of X4-tropic
viruses on CXCR4+ cell turnover within the memory compart-
ment. When we investigated disappearance rates of CCR52 cells
according to CXCR4 expression, the CXCR42 cells appeared to
have a long survival in the circulation (Table S2).
4. Naı¨ve (CD45R02) CD4+ T-cell turnover is slow,
irrespective of CXCR4 expression status. CXCR4 tends
to be expressed on naı¨ve T-cells rather than memory cells. Since it
is known that naı¨ve T-cells have much slower rates of in vivo
Figure 1. Relationship between CCR5 expression and proliferation, disappearance and phenotype in CD45R0+ CD4+ memory T-
cells. (A,B) Deuterium enrichment plots expressed as fraction of labeled CD45R0+ CD4+ memory T-cells from a one-day labeling experiment. Cells are
compared according to CCR5 expression: circles, CCR5+; squares, CCR52. Representative data are shown from one typical control subject (A) and one
HIV-positive subject (B). Modeled proliferation (C, D) and disappearance (E, F) rate constants for CD45R0+ memory CD4+ T-cell subsets defined by
CCR5 expression in healthy (C,E) and HIV+ (D,F) subjects. Symbols denote cell type: circles, CCR5+; squares, CCR52; horizontal bar, mean, P values by
paired t-test.
doi:10.1371/journal.ppat.1003310.g001
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Table 2. Modeled proliferation rates for CD4+ T-cell subpopulations.
Cell phenotype
CD4+ CD45R0+
CCR5+
CD4+ CD45R0+
CCR52 CXCR42
CD4+ CD45R0+
CCR52 (all)
CD4+ CD45R0+
CCR52 CXCR4+
CD4+ CD45R02
CXCR42
CD4+ CD45R02
CXCR4+
Controls
C27RR n/a 1.40 0.95 0.20
RC01 n/a 1.48 0.76
RC02 n/a 2.64 2.22 0.35
RC03 n/a 2.68 1.28 0.83
RC04 2.93 1.72 0.56 0.29
RC05 n/a 1.04 0.28 0.28
RC06 0.89 0.77 0.51 0.22
RC07 5.01 2.68 1.86 0.89
RC08 3.16 2.22 0.42 1.25
RC09 1.67 1.24 0.56 0.24
RC10 2.60 1.59 0.63 0.69
RC11 1.59 0.62 0.44 0.91
RC12 2.14 0.74 0.49 0.31
mean 2.50** 1.60 0.84 0.54
SD 1.26 0.75 0.59 0.36
n 8 13 13 12
HIV-positive
R5-tropic
RH02 4.42 2.16 2.03 1.94 0.51
RH04 5.77 1.61 1.21 1.61 1.10
RH05 5.22 2.66 2.50 0.67 0.53
RH06 5.85 1.90 1.52 1.97 0.81
RH07 19.07 2.07 2.39 2.64 1.02
RH08 2.66 1.60 1.59 0.76 0.36
RH10 2.28 2.51 2.45 1.98 0.72
RH12 1.46 1.71 1.57 0.92 0.82
RH13 3.05 4.73 4.45 1.24 0.64
R5-mean 5.53 2.33 2.19 1.52 0.72
R5-SD 5.32 0.97 0.97 0.67 0.24
R5 HIV dynamic factor 2.21 1.37 1.34
X4-tropic
RH01 2.40 n/a 1.33 n/a 1.16 0.49
RH09 6.46 4.58 4.46 1.54 0.58
RH11 5.85 2.42 2.38 2.17 0.61
RH14 2.61 2.88 2.71 0.93 0.07
X4-mean 4.33 3.29 2.72 1.55 0.44
X4-SD 2.13 1.13 1.30 0.62 0.25
X4 HIV dynamic factor 1.73 1.70 0.81
All HIV-positive
mean 5.16{* 2.571 2.351 1.53" 0.63
SD 4.51 1.24 1.05 0.74 0.27
All HIV dynamic factor 2.07 1.47 1.18
Values represent proportion of labeled cells newly generated per day, normalized for average glucose enrichment. CCR52 cells were sorted by CXCR4 expression in all
HIV subjects (except RH01) but not in controls. n/a, data not available. HIV dynamic factor represents the mean proportional effect of HIV infection on turnover rates
compared to controls. In order to avoid multiple comparisons, values for proliferation rate were only compared within corresponding cell-types between subject groups
(control versus ‘‘All HIV-positive’’ subjects, not with separate HIV-positive subgroups),
{P,0.05 versus control subjects for CCR5+ and.
1P,0.05 for CCR52 cells, unpaired t-test; within cell-type between HIV groups (no significant differences); and between corresponding cell-types (chemokine receptor
positive versus negative) within subject groups,
*P,0.05,
**P,0.01 CCR5+ versus CCR52 cells,
"P,0.05 CXCR4+ versus CXCR42 CCR52 cells, paired t-tests.
doi:10.1371/journal.ppat.1003310.t002
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turnover than memory cells,[19,21] we hypothesized that
CXCR4-expressing cells might represent a subset with slower
turnover prior to HIV infection. We did not find evidence for such
an effect in this small study (Figure 4A; P = NS); indeed turnover
rates were low in all CD45R02 cells in control subjects. This
comparison was not possible in HIV+ subjects as CD45R02
CXCR4- were only collected in the HIV-sorting protocol in one
subject.
5. Effects of HIV infection on naı¨ve cell turnover are
minor, appear independent of viral tropism, and are
associated with disease progression. When modeled naı¨ve
cell kinetics were compared between control and HIV+ groups, we
found similar turnover rates for ‘‘naı¨ve’’ CD45R02CXCR4+CD4+
T-cells (Figure 4B; Table 2 and Table S1). Overall the effect of HIV
infection on T-cell dynamics (a factor of 1.1860.51) was not
significant. Separating HIV-infected subjects according to viral
tropism demonstrated that the presence of X4-tropic virus was not
associated with any differential increase in proliferation of CXCR4+
cells. Indeed, although numbers were small, it appeared that the
converse was true; CD45R02CXCR4+ cells in subjects with X4-
tropic viral strains tended to have lower, not higher, rates of
proliferation (Table 2 and Table S1; Figure 4B) and disappearance
(7.4 vs 11.8%/day, Table S2). Our findings thus appear contrary to
the predictions of a direct viral pathogenicity model; X4 tropic
Figure 2. HIV infection accelerates turnover rates of CCR5-positive CD4+CD45R0+memory T-cells. (A) Increased proliferation rates in HIV
infected subjects (HIV+ R5, HIV-positive subjects with R5-tropic virus; HIV+ X4, HIV-positive subjects with X4-tropic virus) compared to controls
(P,0.05 by Mann Whitney test as data skewed). (B) Correlation of CCR5+ T-cell turnover with viral load in viremic HIV+ subjects (open circles are
subjects with X4-tropic virus; P = 0.044, r2 = 0.28 using log-transformed data). (C) Phenotype profile of CCR5+ memory T-cells in healthy controls (C,
open symbols) and HIV+ subjects (H, filled symbols). CD62L and CD95 data were not available for control subjects. P = NS for all comparisons between
control and HIV+ by Mann Whitney test.
doi:10.1371/journal.ppat.1003310.g002
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viruses do not appear to preferentially drive turnover of CXCR4+
CD4+ T-cells. However, when we investigated the relationship
between disease progression, using either viral load or CD4 slope as
an index, we found that subjects with higher viral loads and more
rapid CD4 loss had higher rates of proliferation within the naı¨ve
compartment, suggesting that with disease progression turnover
within the naı¨ve compartment is indeed accelerated.
In order to further define the effects of HIV on the CXCR4+
compartment, we performed extended phenotyping (Figure 4C).
In controls, for CD45R0+ cells, CXCR4+ expression was
associated with lower expression of CCR5 (11 vs 29%, medians,
P = 0.036 by Wilcoxon test), and CD25 (4.6 vs 7.5%; P = 0.031).
For CD45R02 CXCR4+ cells, CCR5, CD25, and CD95
expression were all very low; low levels of CD95 would be
consistent with greater longevity. CD28 expression levels tended to
be high and unrelated to CXCR4 expression. HIV infection
resulted in modest up-regulation of CD25 on all cell types, and of
CD95 on CD45R02 cells, whether CXCR4+ or negative
(Figure 4C). A differential effect was seen in CD45R0+ cells with
both CCR7 and CD27, where HIV increased expression of both
markers in CXCR4+ cells but reduced it in CXCR42 cells.
Thus it appears that CXCR4+ cells share many phenotypic
characteristics regardless of their CD45R0/RA status (CD95 being
an exception). Both subpopulations show a similar response to HIV
infection, primarily increased activation as reflected by CD25
expression. Strikingly, however, HIV infection did not appear to
drive differentiation of CXCR4+ cells (or at least not without
transition to CXCR4-negativity) as CD27, CD28 and CCR7
expression remained high. Thus both phenotypic and kinetic data
support the proposition that a small but significant number of cells
are entering an activated state and cycling without leaving the
CXCR4+ compartment, but only as disease progression occurs.
Figure 3. HIV infection increases turnover rates of CCR5-negative CD4+CD45R0+ memory T-cells. HIV infection and turnover rates of
CCR52 memory T-cells, expressed either as peak enrichment (A) or modeled proliferation rate (B) for all CD4+CD45R0+ CCR52 cells, according to
subject group: HIV+ R5, HIV-positive subjects with R5-tropic virus; HIV+ X4, HIV-positive subjects with X4-tropic virus. When CCR52 cells in HIV+
subjects were subdivided by CXCR4 expression (C), the effect of HIV infection was found to be confined to the CXCR42 compartment; x-axis
separated by subject group and cell type; control samples were not subdivided by CXCR4 expression. (D) Relationship between proliferation rates,
CXCR4 expression and viral tropism in CD4+CD45R0+ CCR52 cells in HIV+ subjects.
doi:10.1371/journal.ppat.1003310.g003
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Predictors of CD4 T-cell loss
In order to further elucidate the pathophysiology of T-cell loss
in HIV infection we related kinetic parameters to the rate of
change of CD4 count in the period leading up to the labelling day.
As expected, there was a strong negative correlation between viral
load and rate of change of CD4 count (Figure 5A; r2 = 0.47;
P = 0.005). These two parameters can thus be considered covariate
expressions of disease progression. Thus, the trend towards faster
CCR5+ cell turnover with higher viral loads (Figure 2B) corre-
sponded to similar trend with more rapid CD4 decline (Figure 5B
& C). Correlation of markers of disease progression with turnover
of CCR52 memory cells was not significant in this small study,
whereas there did appear to be a significant relationship with naı¨ve
cell turnover (Figure 5D,E,F), although data were strongly
influenced by rapidly progressing subjects such as RH07. This
subject was studied twice, initially during a phase of rapid CD4 cell
loss and subsequently, 15 months after starting antiretroviral
therapy, with an undetectable viral load (,40 copies/ml) and
Figure 4. CXCR4 expression and turnover in CCR52 memory (CD45R0+) T-cells, CXCR4+ naı¨ve (CD45R02) T-cells and phenotypic
correlates. (A) Proliferation rates in CXCR42 (circles) and CXCR4+ (squares) CCR52 CD45R0+ T cells in healthy controls; horizontal bars represent
means, P = NS by t-test. (B) Modeled proliferation rates in CXCR4+ naive (CD45R02) CD4+T cells from control subjects (circles), HIV-infected subjects
with an R5-tropic virus (squares), and HIV-infected subjects with an X4-tropic virus (diamonds); horizontal bars represent means, P = NS by t-test. (C)
Phenotype of CXCR4+ cells according to CD45 expression, either CD45R0+ (upper panel) or CD45R02 (lower panel). Values are shown from healthy
control subjects (C, open symbols) and HIV+ subjects (H, closed symbols); * indicates significant difference between control and HIV data (P,0.05 by
Mann Whitney test). CD62L data was not available for control subjects.
doi:10.1371/journal.ppat.1003310.g004
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rising CD4 count (from 188 to 558 cell/ul; Figure S2A). Changes
in turnover rates pre-/post-treatment mirrored the between cohort
differences described above. The most dramatic change was a
reduction in the turnover rate of CCR5+ memory cells, by a factor
of more than 6-fold (Figure S2B,S2D), whereas changes in the
turnover rate of CCR52CXCR42 memory cells were less marked.
For CXCR4+ cells in both naı¨ve and memory compartments, a
two-fold reduction in peak labelling was also noted (Figure S2C,
S2D), even though this patient had a predominantly R5-tropic
circulating strain of virus, suggesting that the proliferation-
inducing effects of HIV infection in this subject were not due to
cellular tropism directed, subset-specific effects of viral infection.
Discussion
Previous studies in SIV models [9,27] and ex vivo studies in
humans [28,29] have greatly informed our understanding of
lentivirus immunopathology. Although only a relatively small
descriptive study, this research extends our understanding by
adding directly-measured human in vivo data exploring how CD4
T-cell immune homeostatic responses contribute to HIV patho-
genesis.
Firstly, we found that CCR5 expression normally defines a
subpopulation of memory cells which divide more frequently than
CCR52 memory T-cells; this was true for both healthy and HIV-
infected subjects. This is consistent with the observation that
CCR5 is predominantly expressed on CD45RA2 antigen-primed
memory cells which are known to have higher turnover rates than
their naı¨ve counterparts.[19,21] In the context of HIV infection,
this will render CCR5+ cells more susceptible to HIV infection and
also more likely to be the source of circulating virus in infected
individuals, consistent with a proliferation-based model of early
R5-predominance.[17] Concurrently, CCR5+ cells represent the
subpopulation whose turnover rate is most affected by HIV
infection. By contrast, within the larger CCR52 memory
compartment, increased proliferation was only seen in the
CXCR42 compartment, possibly because activation is associated
with downregulation of CXCR4 expression. Thus the effects of
HIV infection are subpopulation specific. Similar observations
have emerged from analogous studies in CD8 cells using heavy
water labeling; HIV accelerated the turnover of IL-7Ra+ central-
memory cells but not TEMRA cells, which retained a long half-life
and accumulated despite progressive HIV disease.[30]
Expression of CCR5 appears to be critically related to how cells
respond to HIV infection. Upregulation of CCR5 may be both
cause and effect. CCR5 would be expected to be upregulated on
activated cells, but our phenotype data showed that most CCR5+
cells in HIV infection are not highly activated (little Class II or
CD95), although they are more differentiated (reduced CD27).
Greater differentiation may be associated with shorter inter-
mitotic times as shown in previous studies of CD4 T-cells showing
a hierarchy of division rates: TEM.TCM.TN,[20] although in this
study HIV infection was not associated with down-regulation of
CCR7 in CD45R0+CCR5+ cells. Thus it appears likely that both
R5 and X4-tropic HIV strains preferentially drive accelerated
turnover in the CCR5+ compartment (possibly by driving more
cells into a CCR5-expressing phenotype) and promote greater
differentiation within that compartment.
Secondly, we found that, by contrast, naı¨ve (CD45R02CXCR4+)
T-cell homeostatic proliferation remained relatively unaffected by
Figure 5. Correlates of CD4 cell loss in HIV-infected subjects. Relationship of CD4 slope with viral load in all HIV-infected subjects (A); each
symbol represents a single subject; closed circles, R5-tropic subjects; open symbols, X4-tropic subjects; closed square, treated subject (RH07R);
undetectable viral load was attributed the value of 40 copies/mL (the detection threshold), or 1.6 as log10. CD4 cell loss was expressed as a rate of
decline in the months preceding in vivo kinetic studies. Relationship of viral load and CD4 slope with kinetic parameters in memory (CD45R0+CCR5+)
(B, C) and naı¨ve (CD45R02CXCR4+) (D, E, F) CD4+ T-cells; symbols as frame (A); analysis by Pearson linear regression, * log transformed for skewed
CCR5+ data.
doi:10.1371/journal.ppat.1003310.g005
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the maelstrom of immune activation and CCR5+ cell proliferation.
This accords with observations in HIV-infected subjects monitored
by Ki67 expression and ex vivo BrdU incorporation.[29] Similarly, in
patients with acute infectious mononucleosis, we previously
observed a similar phenomenon: massive alterations in
CD8+CD45R0+ memory T-cell kinetics were associated with only
minor changes in CD45RA+ cell kinetics.[31] Slow turnover
CXCR4+ naı¨ve cells thus appear relatively protected from
apoptosis. These measurements however would not include
activation-induced proliferation of naı¨ve cells if such dividing cells
down-regulated CXCR4 and upregulated CCR5; their deuterium
labeling would be apparent in CCR5, not CXCR4-sorted
populations. However, even if this were the case, in a relatively
steady-state situation, as prevails in chronic-phase HIV, most
CXCR4+ cells undergoing phenotype transition would be replaced.
Assuming such replacement is primarily by peripheral cell division
in adult subjects,[21] a labeling signal would still be expected in the
CXCR4+ fraction, although it might be too small to detect in our
relatively small control and HIV+ cohorts. Interestingly, within the
HIV cohort a trend towards accelerated turnover with markers of
disease progression suggests that the onset of accelerated prolifer-
ation in the naı¨ve cell compartment may be a critical tipping-point
beyond which decompensation occurs, precipitating more rapid
CD4 cell decline.[32] . Naı¨ve cells may be difficult to replace, as
they have long inter-mitotic times [21] and replacement depends
upon peripheral T-cell division, particularly in older people with
reduced thymic output [5] (consistent with the faster HIV
progression seen in older patients [33]). Although previous studies
of Ki67 expression have suggested that naı¨ve cells may be brought
into cycle as a homeostatic response to falling CD4 cell numbers in
HIV infection,[18,34] we did not observe any correlation of naı¨ve
cell turnover with absolute CD4 count in this study (possibly
because we selected subjects with relatively high CD4 counts) but we
did observe a trend with rate of CD4 decline and viral load,
surrogate markers of immune activation.
Thirdly, we noted similar patterns of kinetic response to HIV
infection, regardless of viral tropism. Both viruses approximately
doubled turnover of CCR5+ memory cells (p increased by a
factor of of 2.2 and 1.7 for R5 and X4 viruses respectively,
Table 2). We found no evidence of tropism-specific accelerated
turnover in the CXCR4+ compartment for either memory or
naı¨ve cells in subjects with dominant X4-tropic infections.-
Rather, the dominant effect of X4-tropic virus was to drive
accelerated turnover of CCR5+ cells, as seen with R5-tropic
strains. This pattern is similar to that seen in BrdU-labeling
studies in SIV-infected rhesus macaques, where R5 and X4-
tropic viral strains both accelerated memory cell turnover.[27]
This does not rule out a specific effect of this virus type on
CXCR4+ cells as numbers of X4-infected subjects were small,
primarily because patients with X4-tropic virus not embarking
on treatment are uncommon and difficult to identify and
recruit. However, it should be noted that, although subject
numbers were small, when both repeated measurements over
time and replicates at each time-point are considered, our
conclusions are based on 1,585 enrichment measurements. Also,
these findings are based on direct in vivo measurements, which
although difficult and complex to execute, give a genuine
representation of human in vivo HIV pathology. To minimise
staining artefacts we only sorted fresh (not frozen) cells, and used
sodium azide to block co-receptor internalisation.[35] It would
have been very helpful to have sorted further cell types, such as
CXCR4+ and CXCR42 CD45R0+CCR52 subsets from control
subjects and CD8 T-cells; the latter would have been
particularly valuable since CD8 cells may respond quite
differently to HIV.[28,36] However, these additional sorts were
not possible within the clinical and technical constraints of the
project.
Why then does X4 switching appear more pathogenic? Recent
studies of viral env C2V3 sequences have shown that, although
there appears to be little viral compartmentalization among cell
subsets, switching coreceptor usage to X4 results in dramatically
increased infection in naı¨ve cells.[37] If this exceeded homeostatic
mechanisms, then the switch from a R5- to a X4-tropic virus may
indeed represent a pressure that may lead to a slow erosion of
these cells. Mechanistically, IL-7, a type-I cytokine, may have a
critical role in such a switch as levels correlates with CD4 T-cell
depletion.[28,38] IL-7 also appears to increase CD4+ T-cell
surface CXCR4 density, HIV-1 production and the risk of
emergence of X4-tropic strains of virus.[39] In addition, non-
specific activation by cytokines, superantigens, or antigen-specific
recruitment from gut microbial translocation might also drive
naı¨ve cells into clonal expansion. If X4 tropism generated greater
degrees of immune activation,[24] it might explain the positive
correlations observed between CD4 disappearance rate and
CXCR4+ naı¨ve cell proliferation that we observed (Figure 5 E,F).
In conclusion, our directly-measured in vivo human kinetic data
lend further support to an immune activation model of HIV
immunopathogenesis. We hypothesise that the dominant and early
effect of HIV infection is to drive the proliferation of CCR5+ CD4
T-cells, independent of viral tropism, although X4-tropic strains
may generate higher levels of immune activation. Such CCR5+
memory cells are normally relatively short-lived and may therfore
be relatively ‘‘easy’’ to replace. In progressive or late-stage disease,
more naı¨ve cells are driven into cycle, by immune activation
resulting from virus of either tropism. Such naı¨ve cells, with their
low natural rates of turnover and in the presence of thymic
atrophy characteristic of adult humans, are difficult to replace and
cumulative CD4 depletion results. Further kinetic studies could be
designed to address this proposal, focusing on patients with more
advanced disease.
Materials and Methods
Subjects
Ethics statement. Subjects gave written informed consent to
protocols approved by local ethics committees (Wandsworth
Research Ethics Committee) and study procedures were per-
formed in accordance with the principles of the declaration of
Helsinki.
Asymptomatic HIV-1-positive subjects were recruited from
viremic treatment-naı¨ve patients attending an urban HIV clinic;
one aviremic long-term non-progressor was also included in the
regression analyses. Healthy controls were recruited by local
advertisement. Exclusions were: age ,18 or .65, pregnancy, any
active medical condition or opportunistic infection. Baseline
assessment included clinical review, quantitative CD4 count
(Trucount, BD Biosciences), lymphocyte phenotyping and viral
load assay. CD4 slope was calculated by defining the period of
preceding documented clinical stability (up to 30 months) from
clinical records, then linear regression of CD4 counts during the
stable period; this yielded 4–8 time-points per subject over a
median period of 16 months (range 7–30 months). The immune
phenotype of HIV-positive subjects was analyzed according to
expression of CD4, CD45RA, CD45R0, CXCR4, CCR5, CCR7,
CD25, CD27, CD28, CD62L, and CD95 on a BD FACS Calibur
using the following antibodies (sourced from Becton, Dickinson
U.K. Limited, Oxford, UK, unless stated otherwise): CD4-Biotin
(ABD Serotec, Oxford, UK)/Streptavidin PerCp, CD45RO APC
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(Caltag-Medsystems Ltd, Towcester, UK), CXCR4 (CD184)-PE,
CCR5 (CD195)-FITC, CD45RA PE & FITC, Purified mouse
anti-Human CCR7/Goat anti-mouse IgM PE & FITC (South-
ernBiotech, Birmingham, AL), CD25-PE, CD25-FITC (ABD
Serotec), CD27 PE & FITC, CD28 PE & FITC, CD62L PE &
FITC, CD95 PE &FITC. Viral tropism of the dominant
circulating viral strain was determined by sequencing the HIV-1
gp120 V3-loop region using the geno2pheno algorithm (http://
www.geno2pheno.org), the concordance of which with gold-
standard tests is good, especially with higher CD4 cell counts and
non-exposure to antiretroviral therapy;[40] in one case where
PCR failed, the HIV Trofile assay was used (Monogram
Biosciences, San Francisco, CA).
Labeling methodology
In order to measure the proliferation and disappearance rates of
lymphocyte subpopulations, subjects received a labeling dose of
60 g of 6,6-2H2-glucose (Cambridge Isotopes, MA) intravenously
over 24 hours as previously described.[19,25] Samples taken
during labeling showed an average plasma glucose enrichment of
26% (range: 16–35%) over 24 hours. Follow-up heparinized blood
samples were taken on days 3,4,10 and 21 post-labeling to estimate
DNA enrichment; sodium azide (final concentration 0.2%w/v)
was added to prevent internalization of chemokine-receptors
between venepuncture and flow-cytometry.[35] Peripheral blood
mononuclear cells (PBMC) were prepared by density centrifuga-
tion and sorted according to expression of CD4, CD45R0,
CXCR4, and CCR5 by flow-cytometry as shown in Figure S3
(Moflow, Cytomation, Fort Collins, CO). Sorted cells underwent
DNA extraction, digestion and derivatization for analysis by gas
chromatography mass spectrometry (GC/MS) by negative chem-
ical ionization of the pentafluoro tri-acetate derivative of
deoxyadenosine for deuterium enrichment as previously de-
scribed.[41]
Modeling, comparisons and statistics
Peak incorporation of deuterium into DNA of labeled cells was
taken as a minimum estimate of proliferation; by dividing by the
corrected precursor glucose enrichment [25] this may be expressed
as the proportion of labeled cells for a one-day labeling period.
Deuterium enrichment data were modeled using a single
exponential accrual and loss function as described by Asquith et
al [19,42] in Sigmaplot (Systat Software Inc, San Jose, CA), where
fractional deuterium enrichment, F is given by:
F~p
.
d: 1-e-d
t
 
during labeling, and
F~p=d: 1-e-d
t
 
:e-d
 t-tð Þ after labeling,
where t is the sample time and t is the labeling time. This model
yields two parameters: (i) the proliferation rate (p) represents the
rate of replacement of the whole population of interest with newly
synthesized cells and thus indicates population turnover, and (ii)
the disappearance/death rate (d*) which contributes to the
modeled p value but itself only describes the recently-divided
sub-fraction of cells. Proliferation and disappearance rates were
related to surface co-receptor expression and viral phenotype.
Values are shown as mean 61SD, except where ranges are shown
[min-max].To avoid multiple comparisons, statistical comparisons
were made according to an a priori plan (Table 2) using parametric
tests (except where data failed D’Agostino-Pearson normality
testing, when log-transformed data was used) in Prism (GraphPad
Software Inc. La Jolla, CA).
Supporting Information
Figure S1 Phenotypic characteristics of CCR5+ and
CCR52 CD4+ T-cells. Comparison of expression of CD27,
CXCR4 and CCR7 on CCR5+ and CCR52 CD4+ T-cells in
control and HIV-positive subjects; not all control subjects in this
group were fully immunophenotyped so further controls were
included for comparisons of expression profiles. * indicates
significant differences between CCR5+ and CCR52 cells or
between CXCR4+ and CXCR42 cells; *P,0.05, **P,0.001 by
paired t-test); { P,0.05 control vs corresponding HIV positive cell
type.
(TIF)
Figure S2 Effect of anti-retroviral treatment on turn-
over of CD4+ T cell subpopulations. (A) Viral load (open
squares) and CD4 count (closed circles) in subject RH07, who was
infected with an R5-tropic virus, measured before (arrow ‘‘Pre-
treatment’’) and after (‘‘Post-treatment’’) commencing antiretrovi-
ral treatment (date shown by dashed line). (B & C) Corresponding
patterns of turnover of CD4 T cells before (open symbols) and
after treatment (solid symbols). Graphs show deuterium enrich-
ment of DNA from sorted cell populations (expressed as fraction of
new cells per day) for CD45R0+ memory CD4+ T-cells (B),
subdivided into CCR5+ (diamonds) and CCR52 (squares)
subpopulations, and CXCR4 expressing cells (C, note different
y-scale), subdivided into memory (CD45R0+, triangles) and naı¨ve
(CD45R02, circles) subpopulations. (D) Tabulated changes in
turnover rates of subpopulations.
(TIF)
Figure S3 Sorting strategy. Monoclonal antibody-labeled
PBMC were sorted on a MoFlo, allowing simultaneous collection
of four populations. (A) The lymphocyte gate was set using forward
and side scatter parameters and cells were gated on CD4 (B) and
then CD450 versus CXCR4 or CCR5 (C, D).
(TIF)
Table S1 Peak enrichments (minimum proliferation
rates) for CD4+ T-cell subpopulations.
(DOC)
Table S2 Modeled disappearance rates for labeled cells
for CD4+ T-cell subpopulations.
(DOC)
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